CXCR2 is a novel cancer stem-like cell marker for triple-negative breast cancer

BACKGROUND: Breast cancer is the leading cause of mortality from cancer in women worldwide, and cancer stem-like cell (CSC) is responsible for failure treatment of breast cancer. It plays an important role in resistant disease and metastasis. CD44/CD24 and ALDH are well-accepted protein markers of b...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Onco Targets Ther
Päätekijät: Wang, Yuyi, Tu, Li, Du, Chi, Xie, Xiaoxiao, Liu, Yanyang, Wang, Jiantao, Li, Zhixi, Jiang, Ming, Cao, Dan, Yan, Xi, Luo, Feng
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove Medical Press 2018
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6134958/
https://ncbi.nlm.nih.gov/pubmed/30233217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S174329
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia